InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,464.62
(
-0.16%
)
US TECH 100
19,220.00
(
-0.20%
)
Dow Jones
39,150.33
(
0.04%
)
Brent Oil
84.39
(
0.00%
)
Bitcoin
64,100.66
(
-0.22%
)
Post# of 97239
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

BiotechValues

Send PM Follow Ignore
Followers 355
Posts 9910
Boards Moderated 2
Alias Born 06/23/2007

BiotechValues

Re: $heff post# 86575

Wednesday, 03/11/2015 1:17:53 PM

Wednesday, March 11, 2015 1:17:53 PM

Post# of 97239
$ZGNX way oversold. Deal for Zohydro worth $283M w milestones and current market cap of ZGNX < $200M

If the company had no other products in the pipeline I could see the negativity on the sale of Zohydro, but they have Relday which could be a biggie- the first once/month sub-cutaneous injection for schizophrenia. This would help ensure patient compliance in a population well documented to not take meds as prescribed.

http://www.zogenix.com/content/pipeline/relday.htm

IRP Disclosure

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up